Influence of increased c-Myc expression on the growth characteristics of human melanoma

Journal of Investigative Dermatology

Volumn 112, Issue 3, 1999, Pages 332-336

  Schlagbauer Wadl, Hermine ^a   Griffioen, Marieke ^b   Van Elsas, Andrea ^b   Schrier, Peter I ^b   Pustelnik, Tom ^a   Eichler, Hans Georg ^a   Wolff, Klaus ^a   Pehamberger, Hubert ^a   Jansen, Burkhard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

c Myc; Melanoma; Metastasis; SCID mouse

Indexed keywords

ANIMAL MODEL; ARTICLE; COMBINED IMMUNODEFICIENCY; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; SKIN TUMOR; TUMOR GROWTH;

EID: 0032979768     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00506.x     Document Type: Article

References (24)

1. Aubert C, Rouge F, Galindo JR: Tumorigenicity of human malignant melanocytes in nude mice and their differentiation in vitro. J Natl Cancer Inst 64:1029-1038, 1980
2. Bosma GC, Custer RP, Bosma MJ: A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530, 1983
3. Bouchard C, Staller P, Eilers M: Control of cell proliferation by Myc. Trends Cell Biol 8:202-206, 1998
4. Custer RP, Bosma GC, Bosma MJ: Severe combined immunodeficiency (SCID) in the mouse. Am J Pathol 120:464-477, 1985
5. Evan GI, Littlewood TD: The role of c-myc in cell growth. Curr Opin Genet Dev 3:44-49, 1993
6. Goodman LA, Liu BCS, Thiele CJ, et al: Modulation of N-myc expression alters the invasiveness of neuroblastoma. Clin Exp Metastasis 15:130-139, 1997
7. Griffioen M, Peltenburg LTC, Oorschot D, Schrier PI: C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically. Immunobiology 193:238-247, 1995
8. Grover R, Ross DA, Richman PI, Robinson B, Wilson GD: C-myc oncogene expression in human melanoma and its relationship with tumor antigenicity. Eur J Surg Oncol 22:342-346, 1996
9. Grover R, Ross DA, Wilson GD, Sanders R: Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma. Br J Plast Surg 50:478-482, 1997a
10. Grover R, Grobbelaar AO, Hudson DA, Forder M, Wilson GD, Sanders R: The clinical significance of oncogene expression in subungual melanoma. Br J Plast Surg 50:15-19, 1997b
11. Henriksson M, Lüscher B: Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-181, 1996
12. Jansen B, Inoue SA, Wadl H, Eichler HG, Wolff K, Van Elsas A, Pehamberger H: N-ras oncogene expression changes the growth characteristics of human melanoma in two independent SCID-hu mouse models. Int J Cancer 67:821-825, 1996
13. Jansen B, Schlagbauer-Wadl H, Eichler HG, Wolff K, Van Elsas A, Schrier PI, Pehamberger H: Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis. Cancer Res 57:362-365, 1997
14. Judware R, Culp LA: Overexpression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of β1 integrin subunit. Oncogene 11:2599-2607, 1995
15. Korabiowska M, Brinck U, Mirecka J, Kellner S, Marx D, Schauer A: Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions. In Vivo 9:433-438, 1995
16. Kozma L, Kiss I, Szakall S, Ember I: Investigation of c-myc oncogene amplification in colorectal cancer. Cancer Lett 81:165-169, 1994
17. Kretzner L, Blackwood EM, Eisenman RN: Myc and Max proteins possess distinct transcriptional activities. Nature 359:426-429, 1992
18. Lazaris AC, Theodoropoulos GE, Aroni K, Saetta A, Davaris PS: Immunohistochemical expression of c-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma. Virchows Arch 426:461-467, 1995
19. Peltenburg LTC, Steegenga WT, Krüse MK, Schrier PI: C-myc induced natural killer cell sensitivity of human melanoma cells is reversed by HLA-B27 transfection. Eur J Immunol 22:2737-2740, 1992
20. Prins J, de Vries EGE, Mulder NH: The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumor types. Anticancer Res 13:1373-1386, 1993
21. Ross DA, Wilson GD: Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma. Br J Surg 85:46-51, 1998
22. Vastrik I, Makela TP, Koskinen PJ, Klefstrom J, Alitalo K: Myc protein: partners and antagonists. Crit Rev Oncog 5:59-68, 1994
23. Versteeg R, Noordermeer IA, Krüse-Wolters KM, Ruiter DJ, Schrier PI: C-myc down-regulates class I HLA expression in human melanomas. EMBO J 7:1023-1029, 1988
24. Versteeg R, Peltenburg LTC, Plomp AC, Schrier PI: High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells. J Immunol 143:4331-4337, 1989